Medications for Juvenile Arthritis

5 results
  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
  • hulio - adalimumab - fkjp

    (Adalimumab-Fkjp)
    Biocon Biologics Inc
    Hulio (adalimumab) is a TNF blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults; JIA and Crohn's disease also cover pediatric patients.
  • humira - adalimumab

    (Adalimumab)
    Abbvie Inc.
    HUMIRA is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, juvenile idiopathic arthritis, and non-infectious uveitis in adults and eligible pediatric patients.
  • vimovo

    (Naproxen And Esomeprazole Magnesium)
    Horizon Therapeutics Usa, Inc.
    Vimovo (naproxen/esomeprazole) treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis in adults, and juvenile idiopathic arthritis in adolescents 12+ years weighing at least 38 kg, while reducing the risk of naproxen-associated gastric ulcers.
  • yusimry - adalimumab - aqvh injection, solution

    (Adalimumab-Aqvh)
    Coherus Biosciences Inc
    YUSIMRY is a TNF blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis (age 2+), psoriatic arthritis, ankylosing spondylitis, Crohn's disease (age 6+), ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.